PORTHOS - PORTuguese Heart failure Observational Study - PORTHOS

Study identifier:D1699R00015

ClinicalTrials.gov identifier:NCT05434923

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

PORTHOS - PORTuguese Heart failure Observational Study: a Nationwide Epidemiological Study on Heart Failure and Asymptomatic Left Ventricle Systolic Dysfunction based on Contemporary Diagnostic Tools

Medical condition

heart failure

Phase

Phase 4

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

6189

Study type

Observational

Age

50 Years - n/a

Date

Study Start Date: 30 Jun 2022
Primary Completion Date: 18 Sept 2023
Study Completion Date: 18 Sept 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Aug 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

Sociedade Portuguesa de Cardiologia, NOVA Medical School

Inclusion and exclusion criteria